Match!
Veena Chantarangkul
University of Milan
143Publications
37H-index
4,373Citations
Publications 146
Newest
#1Armando Tripodi (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)H-Index: 33
#2Genny Raffaeli (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)H-Index: 5
Last.Stefano Ghirardello (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)H-Index: 8
view all 10 authors...
Abstract Preterm newborns are considered at risk of acquired coagulopathy and are often prophylactically infused with fresh frozen plasma (FFP) even in the absence of bleeding. To assess the coagulation asset of preterm neonates and the biological plausibility of such infusions, we investigated at birth 87 very low birth weight (≤1500 g) preterm (gestational age
Source
#1Giordano Sigon (University of Milan)
#2Roberta D’Ambrosio (University of Milan)H-Index: 16
Last.Anna Ludovica Fracanzani (University of Milan)H-Index: 48
view all 12 authors...
Source
#1Armando TripodiH-Index: 45
#2Veena ChantarangkulH-Index: 37
Last.Flora Peyvandi (University of Milan)H-Index: 58
view all 6 authors...
Emicizumab is a bi-specific humanized monoclonal antibody mimicking the factor (F) VIII cofactor activity in mediating the activation of FX by FIXa. Recent observations showed that emicizumab when added to pooled normal plasma (PNP), hemophilic plasma or PNP added with unfractionated heparin is able to interfere with coagulation assays. To further explore the mechanisms of assay interference we investigated the effect of emicizumab on global coagulation assays for the PNP added with two direct o...
Source
#1Eugenia Biguzzi (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)H-Index: 17
#2S. M. Siboni (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)H-Index: 13
Last.Armando Tripodi (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)H-Index: 33
view all 8 authors...
Source
#1Armando TripodiH-Index: 45
#2Massimo PrimignaniH-Index: 34
Last.Flora Peyvandi (University of Milan)H-Index: 58
view all 11 authors...
Obesity is a risk factor for cardiovascular diseases. The latter being dependent (at least in part) on plasma procoagulant imbalance (i.e., hypercoagulability). Information on hypercoagulability associated with obesity is scanty and mainly based on global traditional coagulation tests or on the measurement of individual components of coagulation (i.e., pro- and anticoagulants). Plasma from 33 obese subjects was investigated soon before endoscopic balloon placement and after removal (6 months lat...
Source
Source
#1Armando TripodiH-Index: 45
#2Veena ChantarangkulH-Index: 37
Last.Flora Peyvandi (University of Milan)H-Index: 58
view all 4 authors...
Background: Until recently, clinical laboratories have monitored hemophilia treatment by measuring coagulation factors before/after infusion of human-derived or recombinant factors. Substantial changes are expected in the near future based on new therapeutic approaches that have been or are being developed. Content: Hemophilia treatment includes replacement therapy with human-derived/recombinant factors or treatment with bypassing agents for patients without or with inhibitors, respectively. Acc...
2 CitationsSource
Source
#1Armando TripodiH-Index: 45
#2Veena ChantarangkulH-Index: 37
Last.Elena SantagostinoH-Index: 48
view all 7 authors...
Source
#1Stefano Ghirardello (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)H-Index: 8
#2Genny Raffaeli (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)H-Index: 5
Last.Armando Tripodi (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico)H-Index: 33
view all 8 authors...
Abstract Background and aims Despite the potential benefits of thromboelastography (TEG) for bedside hemostatic assessment in critical care settings, its accuracy remains to be determined, especially in critically ill neonates. We determined the intra-assay reproducibility of TEG parameters: Reaction time (R), clot kinetics (K) and Maximum Amplitude (MA) in a cohort of very low birth weight (VLBW) infants. Study design Observational study. Subjects One hundred VLBW newborns. Outcome measures We ...
Source
12345678910